155 related articles for article (PubMed ID: 3728282)
1. Effect of quinidine and bretylium on defibrillation energy requirements.
Dorian P; Fain ES; Davy JM; Winkle RA
Am Heart J; 1986 Jul; 112(1):19-25. PubMed ID: 3728282
[TBL] [Abstract][Full Text] [Related]
2. Effect of lidocaine and bretylium on energy requirements for transthoracic defibrillation: experimental studies.
Kerber RE; Pandian NG; Jensen SR; Constantin L; Kieso RA; Melton J; Hunt M
J Am Coll Cardiol; 1986 Feb; 7(2):397-405. PubMed ID: 3944361
[TBL] [Abstract][Full Text] [Related]
3. Lidocaine causes a reversible, concentration-dependent increase in defibrillation energy requirements.
Dorian P; Fain ES; Davy JM; Winkle RA
J Am Coll Cardiol; 1986 Aug; 8(2):327-32. PubMed ID: 3734254
[TBL] [Abstract][Full Text] [Related]
4. Deleterious effects of bretylium on hemodynamic recovery from ventricular fibrillation.
Euler DE; Zeman TW; Wallock ME; Scanlon PJ
Am Heart J; 1986 Jul; 112(1):25-31. PubMed ID: 3728284
[TBL] [Abstract][Full Text] [Related]
5. Lack of effect of bretylium tosylate on electrical ventricular defibrillation in a controlled study.
Koo CC; Allen JD; Pantridge JF
Cardiovasc Res; 1984 Dec; 18(12):762-7. PubMed ID: 6518459
[TBL] [Abstract][Full Text] [Related]
6. Bretylium (Bretylol) for ventricular arrhythmias.
Med Lett Drugs Ther; 1978 Dec; 20(24):105-6. PubMed ID: 713969
[No Abstract] [Full Text] [Related]
7. Effects of bretylium tosylate on inhomogeneity of refractoriness and ventricular fibrillation threshold in canine hearts with quinidine-induced long QT interval.
Inoue H; Toda I; Nozaki A; Matsuo H; Sugimoto T
Cardiovasc Res; 1985 Oct; 19(10):655-60. PubMed ID: 4053141
[TBL] [Abstract][Full Text] [Related]
8. Bretylium decreases and verapamil increases defibrillation threshold in pigs.
Jones DL; Kim YH; Natale A; Klein GJ; Varin F
Pacing Clin Electrophysiol; 1994 Aug; 17(8):1380-90. PubMed ID: 7971399
[TBL] [Abstract][Full Text] [Related]
9. The effect of newer antiarrhythmic drugs on defibrillation threshold.
Tacker WA; Niebauer MJ; Babbs CF; Combs WJ; Hahn BM; Barker MA; Seipel JF; Bourland JD; Geddes LA
Crit Care Med; 1980 Mar; 8(3):177-80. PubMed ID: 7363635
[TBL] [Abstract][Full Text] [Related]
10. Effects of bretylium tosylate on the in vivo fibrillating canine ventricle.
Breznock EM; Kagan K; Hibser NK
Am J Vet Res; 1977 Jan; 38(1):89-94. PubMed ID: 835872
[TBL] [Abstract][Full Text] [Related]
11. Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate.
Kabell G
J Cardiovasc Pharmacol; 1989 Mar; 13(3):471-82. PubMed ID: 2471895
[TBL] [Abstract][Full Text] [Related]
12. Quinidine syncope. A report of successful treatment with bretylium tosylate.
VanderArk CR; Reynolds EW; Kahn DR; Tullett G
J Thorac Cardiovasc Surg; 1976 Sep; 72(3):464-7. PubMed ID: 957762
[TBL] [Abstract][Full Text] [Related]
13. The relationship between successful defibrillation and delivered energy in open-chest dogs: reappraisal of the "defibrillation threshold" concept.
Davy JM; Fain ES; Dorian P; Winkle RA
Am Heart J; 1987 Jan; 113(1):77-84. PubMed ID: 3799444
[TBL] [Abstract][Full Text] [Related]
14. Bretylium tosylate: a review.
Bryan CK; Darby MH
Am J Hosp Pharm; 1979 Sep; 36(9):1189-92. PubMed ID: 386786
[TBL] [Abstract][Full Text] [Related]
15. Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias.
Heissenbuttel RH; Bigger JT
Ann Intern Med; 1979 Aug; 91(2):229-38. PubMed ID: 380436
[TBL] [Abstract][Full Text] [Related]
16. Effects of flecainide on defibrillation thresholds in the anesthetized dog.
Hernandez R; Mann DE; Breckinridge S; Williams GR; Reiter MJ
J Am Coll Cardiol; 1989 Sep; 14(3):777-81. PubMed ID: 2504799
[TBL] [Abstract][Full Text] [Related]
17. [Bretylium tosylate as an anti-arrhythmic drug].
Steffen V; Fiehring H
Z Gesamte Inn Med; 1976 Nov; 31(22):913-9. PubMed ID: 798429
[TBL] [Abstract][Full Text] [Related]
18. Comparison of bretylium tosylate and lidocaine in management of out of hospital ventricular fibrillation: a randomized clinical trial.
Haynes RE; Chinn TL; Copass MK; Cobb LA
Am J Cardiol; 1981 Aug; 48(2):353-6. PubMed ID: 7023224
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiologic effects of bretylium tosylate on the canine heart during coronary artery occlusion and reperfusion.
Gibson JK; Stewart JR; Li YP; Lucchesi BR
J Cardiovasc Pharmacol; 1983; 5(4):517-24. PubMed ID: 6193345
[TBL] [Abstract][Full Text] [Related]
20. Bretylium in severe ventricular arrhythmias associated with digitalis intoxication.
Vincent JL; Dufaye P; Berre J; Kahn RJ
Am J Emerg Med; 1984 Nov; 2(6):504-6. PubMed ID: 6529463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
